All Press Releases
PILA PHARMA publishes interim report (1 January – 30 June 2024)
Malmö, 27 August, 2024 PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s interim report for the period January - June 2024. The report can be found on the Company´s website: https://pilapharma.com/investors/finansiell-information/ SUMMARY OF INTERIM REPORT First Half year (1 January - 30 June 2024) Operating income amounted to TSEK 683 (1 097) The operating result (EBIT) totalled to…
PILA PHARMA INVITES TO INVESTOR Q&A & PRESENTATIONS
Malmö, August 26, 2024 PILA PHARMA AB (publ) (FN STO: PILA) hereby invites interested investors to participate in our scheduled events in the coming week:___________Stokk.io Online Webinar - H2 Report (ONLINE)Tuesday, August 27, 2024 from 12:00 CET Malmö, August 26, 2024 Aktiespararna Online Life Science Day (ONLINE)Wednesday, August 28, 2024 from 20:00 CETRedeye Online Investor Event (ONLINE)Thursday, August 29, 2024 from…
PILA PHARMA’S BOARD OF DIRECTORS ANNOUNCES COMPLETION OF A FULLY SUBSCRIBED DIRECTED ISSUE OF APPROXIMATELY SEK 10 MILLION
Malmö, 25 July 2024 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE FURTHER REGISTRATION…